
3.54 Delayed Data As of Jun 09 | ![]() Today’s Change | 3.42 Today|||52-Week Range 8.74 | -30.00% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Diffusion Pharmaceuticals Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +1,029.94% increase from the last price of 3.54.
The current consensus among 1 polled investment analysts is to Buy stock in Diffusion Pharmaceuticals Inc. This rating has held steady since August, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.